Background Human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) was the first human
retrovirus discovered and there is an estimate of 15–20 million infected worldwide. Endemic …

Decline in the Positive Rate of HumanT-Lymphotropic Virus iype-1 (HTLV-1) Antibodies
amongBlood Donors in Nagasaki Page 1 ORIGINAL ARTICLE Decline in the Positive Rate of …

Phylogenetic analysis of HTLV‐I variants persisting among population of Turkmenistan and
the Republic of Georgia (situated on both sides of the Caspian sea, not far from a known …

BACKGROUND:: HTLV-2 infection is prevalent among intravenous drug users (IDUs), which
often are coinfected with HIV-1. Two main subtypes, HTLV-2a and-2b, have been described …

The presence of infection by human T cell lymphotropic virus type 1 (HTLV-1) in Cuba has
been previously documented. However, genetic information on the strains that circulate in …

BACKGROUND: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the
general population and 0.7% in blood donors in northeast Iran. It is very important that we …

Background-HTLV is a lymphotropic virus which can contribute to carcinogenesis in adult T-
cell leukemia. The prevalence of this virus in Northeastern Iran has led us to investigate …

Introduction: Transfusion-transmitted infections (TTI) continue to be a major challenge for
Blood transfusion organizations in the world and multi-transfused patients (MTPs) are at …

In Brazil, human T-lymphotropic virus type 2 (HTLV-2) is endemic in Amerindians and
epidemic in intravenous drug users (IDUs). The long terminal repeat (LTR) is the most …

Human T lymphocytotropic virus HTLV is a virus from retroviridae family, and more than 20
million people are infected with this virus worldwide. It can cause leukemia/lymphoma in …